Alpenglow Biosciences, a leader in 3D spatial biology, proudly announces the launch of LUMI, an intuitive user interface designed to integrate smart microscopy into the light-sheet workflow. Attendees of the Association of Biomolecular Resource Facilities (ABRF) 2025 Annual Meeting will get an exclusive first look at LUMI’s capabilities.
LUMI (Light-Sheet User Microscope Interface) is the latest innovation for Alpenglow’s 3D i™ Hybrid Open-Top Light-Sheet (HOTLS) microscope, providing a seamless and user-friendly imaging experience. Built for researchers seeking high-resolution, 3D imaging of biological specimens, LUMI enhances workflow efficiency and data acquisition through its key features:
- Intuitive Scan Setup – Streamlined scan configurations allow users to set up imaging parameters effortlessly.
- Live Preview Mode – Real-time previews provide immediate feedback on scan quality, with Scout Mode offering a wide-field overview for quickly identifying regions of interest, and Zoom Mode delivering high-resolution imaging for capturing intricate details with precision.
- Seamless Operation – A user friendly experience reduces the learning curve for advanced light-sheet microscopy.
- Smart Microscopy – Ability to create algorithms for automated region of interest detection and Scout-to-Zoom workflows.
“With LUMI, we’re making high-throughput 3D imaging more accessible than ever,” said Nicholas P. Reder, MD, MPH, CEO founder and co-inventor at Alpenglow Biosciences. “Researchers can now easily navigate complex microscopy workflows with an interface designed for efficiency.”
Alpenglow Biosciences will be presenting LUMI at ABRF 2025. Attendees are invited to reserve a 1:1 meeting with Steve Pemberton, SVP of Commercial Operations at Alpenglow Biosciences, for discussions on how this breakthrough technology is shaping the future of spatial biology.
About Alpenglow Biosciences
Alpenglow Biosciences is a venture-backed company focused on accelerating drug development and improving clinical diagnostics with AI-enabled 3D imaging technology. Their 3D spatial biology platform solution provides new spatial biology insights with greater accuracy by non-destructively digitizing entire tissues. Alpenglow partners with pharmaceutical companies to bring better therapeutics to market faster through greater understanding of mechanism of action, efficacy & toxicology, and patient trial enrollment using their patented platform. Five of the top 10 pharma companies already work with Alpenglow to accelerate development timelines, save costs, gain new insights, and improve therapeutic success. See what you’ve been missing at alpenglowbiosciences.com. www.alpenglowbiosciences.com.
#SpatialBiology, #3Dimaging, #LightSheetMicroscopy, #Microscopy, #LifeSciences, #ABRF2025, #LUMIImaging, #HOTLSMicroscope, #3Dpathology, #AlpenglowBiosciences
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320498822/en/